Newscast – Page 75 – media

AbbVie pressurized to keep low price for Imbruvica formula

This year AbbVie launched Imbruvica, a single tablet for blood cancer treatment. It has been designed as a convenient therapy measure for patients who used the old tablets as often as four times a day. Adapting the new single tablet in their treatment regimens will prove to be an expensive proposition for some patients as the new tablet comes with a price tag of $400 each, triple the cost of the older tablets.
- Source: Ddu
- 1,136
- May 17, 2018
AbbVie Company Insight pharma pharmaceutical
The imperative for securing connected medical devices

The implementation of privacy protocols and security controls is pertinent to protecting patient records and sensitive data. However, the threat to patient safety, the core of every modern health system, being compromised is growing rapidly owing to network-connected medical devices.
- Source: Ddu
- 687
- May 17, 2018
digital health Market Views medical device
Odour Orders Malarial Transmission

A simple key strategy discovered by the research team at the London School of Tropical Medicine, will turn out to be a major breakthrough in the field of Malarial prevention. Malaria-infected children were more prone to malarial mosquitoes by producing distinctive skin smells, compared to uninfected children.
- Source: Ddu
- 521
- May 17, 2018
malaria Researches
Breakdown of Pharma Events Since 2017

As a new, erratic administration consolidated its position in the White House and firmed its foundations in the federal government, 2017 turned out to be uncertain for the biopharma industry. Then President-elect Donald Trump saying that the industry was getting away with murder on pricing did not bode well for the industry but more than a year later after the President assuming office, real reform has been spared for biopharma.
- Source: Ddu
- 663
- May 17, 2018
global pharma influencers Market Views pharma
AiCuris Partners with MPI for Antibiotic-Resistance Research

AiCuris along with Prof. Dr. Dr. H.C. Waldmann, Director of the Chemical Biology Department at MPI, will jointly investigate and optimize antibacterial or antiviral compounds, which could be developed into anti-infective drugs.
- Source: Ddu
- 742
- May 17, 2018
anti-infective antibiotic resistance Researches
The Kidney That Wanders – Floating Kidney Disease

It has always been believed that the internal organs stay in the same location in our bodies. But breaking news arose where a young woman in Michigan told doctors that she felt as if a ball was rolling inside her body whenever she moved. Upon being diagnosed, it was found that it was, in fact, not a ball but her right kidney. This condition was termed as ‘Floating Kidney’.
- Source: Ddu
- 932
- May 17, 2018
kidney Researches
New Blood Test for Liver Cancer Shows Promising Results

Liver cancer is the second most common cancer with a high mortality rate worldwide. According to WHO, liver cancer is the fifth most common cancer in men and seventh most common cancer in women. Treatment could be possible only if diagnosed at an early stage. Hence research studies were conducted worldwide to find the most accurate diagnostic tool to detect liver cancer.
- Source: Ddu
- 674
- May 17, 2018
cancer Researches
Attacking the common cold by unshielding its genome

The problem with the common cold is that it isn’t just one virus. It’s a family of viruses that evolve so quickly no one can ever be fully immune to the cold, and developing a vaccine that can tackle all of the variations of the virus is impossible. But what if there were one way to block the ability of all cold viruses from replicating—thereby fending off the sneezing, sore throat and general misery that they cause?
- Source: FierceBiotech
- 561
- May 16, 2018
common cold genome Researches
Feds join lawsuits claiming Insys used strip club visits, super-doses and more to boost Subsys sales

Prosecutors have already charged Insys founder John Kapoor and won guilty pleas from two characters in an ongoing kickbacks probe. Now, the Justice Department has escalated the case by joining in with whistleblowers who've detailed a stunning range of techniques the company allegedly used to push its powerful opioid painkiller.
- Source: FiercePharma
- 663
- May 16, 2018
Company Insight lawsuit pharma
U.S. healthcare to be disrupted through a low-cost health network

As America’s population ages, a 4 billion USD opportunity is being foreseen by Thomas DeRosa for changing the U.S. health infrastructure through instituting a low-cost healthcare network and disrupting conventional healthcare practices.
- Source: Ddu
- 626
- May 16, 2018
healthcare Market Views

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.